Department of Radiology, New York University Langone Medical Center, 560 First Ave, TCH-HW202, New York, NY 10016.
The purpose of this article is to review the roles that MRI is expected to play in emerging minimally invasive focal ablative therapies for prostate cancer.
MRI, in combination with biopsy, will impact patient selection for focal ablation by helping to localize clinically significant tumor foci. Also, some ablation procedures may be performed using real-time MRI guidance. In addition, MRI may be used for assessment of extent of necrosis shortly after therapy and for long-term surveillance for recurrent tumor.
Written by:
Rosenkrantz AB, Scionti SM, Mendrinos S, Taneja SS. Are you the author?
Reference: AJR Am J Roentgenol. 2011 Jul;197(1):W90-6.
doi: 10.2214/AJR.10.5946
PubMed Abstract
PMID: 21701001
UroToday.com Prostate Cancer Section
